A promising treatment for Duchenne muscular dystrophy (DMD) could open the way to therapies for cystic fibrosis, spinal muscular atrophy and other disorders.
Children with a deadly muscle-wasting disease are regaining the ability to walk and potentially avoiding life-threatening complications, thanks to a new treatment developed by researchers at Perth’s Murdoch University.